{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-24-007384","form_type":"8-K","ticker":"CBDW","cik":"0001877461","company_name":"1606 CORP.","filed_at":"2024-11-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.217552+00:00","generated_at":"2026-05-29T22:40:18.330824+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"medium","headline":"1606 Corp. files Q3 10-Q, signs LOI with Adnexus Biotechnologies","bullets":["Filed Q3 10-Q for period ended September 30, 2024, maintaining continuous quarterly filings since inception.","Signed Letter of Intent with Adnexus Biotechnologies for a potential strategic investment in AI and biotech.","No financial metrics reported; press release focuses on narrative progress and forward-looking outlook.","CEO plans to close Adnexus investment and expand AI chatbot solutions into healthcare, finance, and telecom."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-24-007384","json":"https://secwatch.observer/filing/0001477932-24-007384.json","markdown":"https://secwatch.observer/filing/0001477932-24-007384.md","text":"https://secwatch.observer/filing/0001477932-24-007384.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1877461/000147793224007384/0001477932-24-007384-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1877461/000147793224007384/onesix_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T22:40:18.330824+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}